We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
Cap. Flow
-$59.5M
Cap. Flow %
-0.14%
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128

Sector Composition

Rank Sector Weight
1 Financials 16.4%
2 Technology 15.29%
3 Healthcare 13.69%
4 Industrials 10.84%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBSB
1976
DELISTED
Meridian Bancorp, Inc.
EBSB
$949K ﹤0.01%
56,168
+64
+0.1% +$1.1K
LSCC icon
1977
Lattice Semiconductor
LSCC
$16B
$947K ﹤0.01%
142,149
-1,398
-1% -$9.57K
UFI icon
1978
UNIFI
UFI
$114M
$941K ﹤0.01%
30,539
+313
+1% +$8.84K
TCRT icon
1979
Alaunos Therapeutics
TCRT
$4.64M
$940K ﹤0.01%
1,007
+53
+6% +$52K
LION
1980
DELISTED
Fidelity Southern Corporation
LION
$940K ﹤0.01%
41,113
+1,310
+3% +$29K
WRLD icon
1981
World Acceptance Corp
WRLD
$861M
$935K ﹤0.01%
12,481
-391
-3% -$26.8K
OSG
1982
Octave Specialty Group
OSG
$257M
$933K ﹤0.01%
53,752
-555
-1% -$9.86K
PI icon
1983
Impinj
PI
$4.24B
$933K ﹤0.01%
+19,170
New +$805K
OMER icon
1984
Omeros
OMER
$845M
$928K ﹤0.01%
46,632
+832
+2% +$14.5K
GABC icon
1985
German American Bancorp
GABC
$1.93B
$927K ﹤0.01%
27,186
+364
+1% +$11.7K
PGNX
1986
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$922K ﹤0.01%
135,737
-32
-0% -$236
TVTX icon
1987
Travere Therapeutics
TVTX
$5.17B
$920K ﹤0.01%
47,454
+2,010
+4% +$36.5K
HAYN
1988
DELISTED
Haynes International, Inc.
HAYN
$920K ﹤0.01%
25,328
-66
-0.3% -$2.48K
CASH icon
1989
Pathward Financial
CASH
$1.88B
$917K ﹤0.01%
30,909
+2,385
+8% +$69.2K
HIBB
1990
DELISTED
Hibbett, Inc. Common Stock
HIBB
$917K ﹤0.01%
44,178
-1,869
-4% -$46K
ACET
1991
DELISTED
Aceto Corp
ACET
$912K ﹤0.01%
59,057
-2,427
-4% -$36.2K
FPO
1992
DELISTED
First Potomac Realty Trust
FPO
$912K ﹤0.01%
82,056
-7,655
-9% -$83.3K
CSTE icon
1993
Caesarstone
CSTE
$69.5M
$908K ﹤0.01%
25,918
+279
+1% +$10.5K
BH icon
1994
Biglari Holdings Class B
BH
$1.2B
$903K ﹤0.01%
3,387
-164
-5% -$44.9K
LNTH icon
1995
Lantheus
LNTH
$6.51B
$903K ﹤0.01%
+51,142
New +$752K
BKS
1996
DELISTED
Barnes & Noble
BKS
$903K ﹤0.01%
118,871
-1,938
-2% -$15.2K
INOV
1997
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$902K ﹤0.01%
68,592
+6,673
+11% +$86.6K
CMTL icon
1998
Comtech Telecommunications
CMTL
$49.7M
$901K ﹤0.01%
47,492
+2,216
+5% +$34.3K
CTBI icon
1999
Community Trust Bancorp
CTBI
$1.42B
$901K ﹤0.01%
20,593
-845
-4% -$37K
XNCR icon
2000
Xencor
XNCR
$1.45B
$900K ﹤0.01%
42,628
+1,955
+5% +$43.8K

Similar funds

RhumbLine Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
  • RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
  • RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
  • RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
  • RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
  • RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.